- Home
- SPCB vs ANVS Comparison
SPCB vs ANVS Comparison
Compare SPCB & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- ANVS
- Stock Information
- Founded
- SPCB 1988
- ANVS 2008
- Country
- SPCB Israel
- ANVS United States
- Employees
- SPCB N/A
- ANVS N/A
- Industry
- SPCB Semiconductors
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- SPCB Technology
- ANVS Health Care
- Exchange
- SPCB Nasdaq
- ANVS Nasdaq
- Market Cap
- SPCB 42.8M
- ANVS 48.3M
- IPO Year
- SPCB N/A
- ANVS 2020
- Fundamental
- Price
- SPCB $10.29
- ANVS $2.43
- Analyst Decision
- SPCB Strong Buy
- ANVS Strong Buy
- Analyst Count
- SPCB 1
- ANVS 4
- Target Price
- SPCB $18.00
- ANVS $17.33
- AVG Volume (30 Days)
- SPCB 98.5K
- ANVS 206.3K
- Earning Date
- SPCB 11-13-2025
- ANVS 11-07-2025
- Dividend Yield
- SPCB N/A
- ANVS N/A
- EPS Growth
- SPCB N/A
- ANVS N/A
- EPS
- SPCB N/A
- ANVS N/A
- Revenue
- SPCB $27,426,000.00
- ANVS N/A
- Revenue This Year
- SPCB N/A
- ANVS N/A
- Revenue Next Year
- SPCB $29.31
- ANVS N/A
- P/E Ratio
- SPCB $14.19
- ANVS N/A
- Revenue Growth
- SPCB 2.17
- ANVS N/A
- 52 Week Low
- SPCB $2.97
- ANVS $1.11
- 52 Week High
- SPCB $18.95
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- SPCB 56.89
- ANVS 49.50
- Support Level
- SPCB $9.40
- ANVS $2.26
- Resistance Level
- SPCB $10.72
- ANVS $2.52
- Average True Range (ATR)
- SPCB 0.51
- ANVS 0.11
- MACD
- SPCB 0.16
- ANVS 0.02
- Stochastic Oscillator
- SPCB 79.72
- ANVS 71.94
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.